摘要 : Several studies in the last decade have highlighted the role of the type I interferon (IFN-I) pathway, and particularly interferon alpha (IFNα) in SLE pathogenesis. As a result, a multitude of potential treatments targeting IFNα h... 展开
作者 | Kirou~K.A. Gkrouzman~E. |
---|---|
作者单位 | |
期刊名称 | 《Clinical immunology: The official journal of the Clinical Immunology Society》 |
总页数 | 10 |
语种/中图分类号 | 英语 / R392 |
关键词 | Clinical trial Interferon alpha Plasmacytoid dendritic cells Systemic lupus erythematosus |
馆藏号 | N2007EPST0000260 |